88 related articles for article (PubMed ID: 24378767)
1. BRCA1 deficiency induces protective autophagy to mitigate stress and provides a mechanism for BRCA1 haploinsufficiency in tumorigenesis.
Tang MK; Kwong A; Tam KF; Cheung AN; Ngan HY; Xia W; Wong AS
Cancer Lett; 2014 Apr; 346(1):139-47. PubMed ID: 24378767
[TBL] [Abstract][Full Text] [Related]
2. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis.
Yeung BH; Kwan BW; He QY; Lee AS; Liu J; Wong AS
Oncogene; 2008 Dec; 27(53):6782-9. PubMed ID: 18776923
[TBL] [Abstract][Full Text] [Related]
3. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
4. Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations.
Maor S; Yosepovich A; Papa MZ; Yarden RI; Mayer D; Friedman E; Werner H
Cancer Lett; 2007 Nov; 257(2):236-43. PubMed ID: 17766039
[TBL] [Abstract][Full Text] [Related]
5. Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line.
Annab LA; Hawkins RE; Solomon G; Barrett JC; Afshari CA
Breast Cancer Res; 2000; 2(2):139-48. PubMed ID: 11056686
[TBL] [Abstract][Full Text] [Related]
6. Dominant-negative activity of a Brca1 truncation mutant: effects on proliferation, tumorigenicity in vivo, and chemosensitivity in a mouse ovarian cancer cell line.
Sylvain V; Lafarge S; Bignon YJ
Int J Oncol; 2002 Apr; 20(4):845-53. PubMed ID: 11894135
[TBL] [Abstract][Full Text] [Related]
7. [BRCA1 regulates progesterone receptors A and B protein expressions in breast cancer cells in vitro].
Guo YX; Zeng WS; Liu YW; Li YS; Lin J; Xiong JB; Luo SQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1157-60. PubMed ID: 18676251
[TBL] [Abstract][Full Text] [Related]
8. Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.
Wolf I; Laitman Y; Rubinek T; Abramovitz L; Novikov I; Beeri R; Kuro-O M; Koeffler HP; Catane R; Freedman LS; Levy-Lahad E; Karlan BY; Friedman E; Kaufman B
Oncogene; 2010 Jan; 29(1):26-33. PubMed ID: 19802015
[TBL] [Abstract][Full Text] [Related]
9. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.
Salceda S; Tang T; Kmet M; Munteanu A; Ghosh M; Macina R; Liu W; Pilkington G; Papkoff J
Exp Cell Res; 2005 May; 306(1):128-41. PubMed ID: 15878339
[TBL] [Abstract][Full Text] [Related]
10. BRCA1: the enigma of tissue-specific tumor development.
Monteiro AN
Trends Genet; 2003 Jun; 19(6):312-5. PubMed ID: 12801723
[TBL] [Abstract][Full Text] [Related]
11. RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain.
Campos B; Díez O; Domènech M; Baena M; Balmaña J; Sanz J; Ramírez A; Alonso C; Baiget M
Hum Mutat; 2003 Oct; 22(4):337. PubMed ID: 12955719
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 185delAG mutant protein, BRAt, up-regulates maspin in ovarian epithelial cells.
O'Donnell JD; Linger RJ; Kruk PA
Gynecol Oncol; 2010 Feb; 116(2):262-8. PubMed ID: 19906413
[TBL] [Abstract][Full Text] [Related]
13. Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: a possible molecular link between stress and breast cancer.
Antonova L; Mueller CR
Genes Chromosomes Cancer; 2008 Apr; 47(4):341-52. PubMed ID: 18196591
[TBL] [Abstract][Full Text] [Related]
14. The HIV protease inhibitor saquinavir induces endoplasmic reticulum stress, autophagy, and apoptosis in ovarian cancer cells.
McLean K; VanDeVen NA; Sorenson DR; Daudi S; Liu JR
Gynecol Oncol; 2009 Mar; 112(3):623-30. PubMed ID: 19147209
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 and p53 protein expression in cultured ovarian surface epithelial cells derived from women with and without a BRCA1 germline mutation.
Piek JM; Dorsman JC; Massuger LF; Ansink AC; Weegenaar J; Shvarts A; Kenemans P; Verheijen RH
Arch Gynecol Obstet; 2006 Oct; 274(6):327-31. PubMed ID: 16826413
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 Gene Mutations and Influence of Chemotherapy on Autophagy and Apoptotic Mechanisms in Egyptian Breast Cancer Patients.
Abdel-Mohsen MA; Ahmed OA; El-Kerm YM
Asian Pac J Cancer Prev; 2016; 17(3):1285-92. PubMed ID: 27039761
[TBL] [Abstract][Full Text] [Related]
17. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
18. BRCA1-hapoinsufficiency: Unraveling the molecular and cellular basis for tissue-specific cancer.
Sedic M; Kuperwasser C
Cell Cycle; 2016; 15(5):621-7. PubMed ID: 26822887
[TBL] [Abstract][Full Text] [Related]
19. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
[TBL] [Abstract][Full Text] [Related]
20. Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation.
Jeng YM; Cai-Ng S; Li A; Furuta S; Chew H; Chen PL; Lee EY; Lee WH
Oncogene; 2007 Sep; 26(42):6160-6. PubMed ID: 17420720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]